Topline Phase 2 Trial Results of ARG-007 in AIS Patients
Released 02 Sep 25
Latest announcements
Ask a question
Your question will be visible to everyone.
Investor Q&As
Start the conversation
Ask Argenica Therapeutics a question about this announcement.